09.03.2018
- Martin Shkreli, who gained notoriety in 2015 for jacking up the price of Daraprim (pyrimethamine), a 62-year-old drug used to treat toxoplasmosis, has been ordered by a US federal...
09.08.2017
- Martin Shkreli, the eccentric former CEO of Turing Pharmaceuticals, who made headlines in 2015 by jacking up the price of Daraprim (pyrimethamine), a 62-year-old drug used to treat...
22.12.2015
- Martin Shkreli, CEO of Turing Pharma, which made headlines by raising the price of the 62-year-old drug, Daraprim (pyrimethamine) from $13.50 to $700 a tablet shortly after...
02.12.2015
- Express Scripts Holding, the biggest pharmacy benefits manager in the US, said it plans to list Imprimis Pharmaceuticals’ cheaper alternative to the toxoplasmosis treatment...
26.10.2015
- California-based Imprimis Pharmaceuticals is touting a customizable compounded formulation of pyrimethamine and leucovorin as a low cost alternative to Daraprim, the drug that made...
30.09.2015
- Shares of US-listed Canadian drugmaker Valeant came under additional severe pressure early this week when Democratic party members on the House of Representative committee on...
25.09.2015
- Turing Pharmaceutical, the company that sparked an angry backlash for raising the US price of Daraprim (pyrimethamine), a drug for treating the deadly parasitic infection...
